Skip to main content
SpringerLink
Log in

In vitro chemosensitivity testing and its clinical application in human gliomas

  • Invited article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Several in vitro chemosensitivity assays have been developed for predicting clinical response to chemotherapeutic and biologic agents, alone and in combinations. The most widely accepted assay is the colony forming assay (CFA) which assesses the clonogenic capability of stem cells. Other methods include growth inhibition assays by evaluating cell number; thymidine incorporation; or amino acid uptake. More recently an automatic colorimetric technique utilizing crystal violet dye or a tetrazolium (MTT) vital dye has been developed for more rapid assessment of cytotoxic or growth inhibitory activity in vitro. Several reports have compared the results of in vitro tests with patients' clinical response. Two major problems affect the predictive value of in vitro chemosensitivity tests. The foremost is cellular heterogeneity which exists within a single tumor as well as between tumors. Artificial selective pressure inherent to tissue culture system is the other problem. In general, in vitro tests predict clinical resistance more consistently than clinical sensitivity. However, chemosensitivity assays remain useful in screening new agents and preclinical modeling of clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bertoncello I, TR Bradley, JJ Campbell, et al.: Limitations of the clonal agar assay for the assessment of primary human ovarian tumor biopsies. Br J Cancer 45 (1982) 803–811.

    Google Scholar 

  2. Bogdahn V: Chemosensitivity of malignant human brain tumors. Preliminary results. J Neuro-Oncol 1 (1983) 149–166

    Google Scholar 

  3. Cancer Statistic, American Cancer Society 1987.

  4. Carmichael J, WG DeGraff, AF Gazdar, et al.: Evaluation of a tetrazolium-based semiautometed colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47 (1987) 936–942

    Google Scholar 

  5. Darling BL, DGT Thomas: Results obtained using assay of intermediate duration and clinical correlations in Dendy PP, Hill BT (eds): Human Tumor Drug Sensitivity Testing in Vitro. Techniques and clinical applications. London: Academic Press (1983) 269–280

    Google Scholar 

  6. Denizot F, R Lang: Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure given improved sensitivity and reliability. J Immunol Methods 89 (1986) 271–277

    Google Scholar 

  7. Feun LG, YY Lee, WKA Yung, et al.: Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Cancer Drug Delivery 3 (1986) 147–156

    Google Scholar 

  8. Fraser LB, G Spitzer, JA Ajani, et al.: Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res 46 (1986) 1263–1274

    Google Scholar 

  9. Freshney RI, D Morgan: Radioisotopic quantitation in microtitration plates by an autofluorographic method. Cell Biol Inst Rep 2 (1978) 375–380

    Google Scholar 

  10. Freshney RI, J Paul, IM Kane: Assay of anticancer drugs in tissue culture: Condition affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer 31 (1978) 89–99

    Google Scholar 

  11. Hamburger AW, SE Salmon: Primary bioassay of human tumor stem cells. Science 197 (1977) 461–463

    Google Scholar 

  12. Hoshino T: A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61 (1984) 895–900

    Google Scholar 

  13. Hoskins JM, GG Meynell, FKA Sanders: A comparison of methods for estimating the viable count of a suspension of tumor cells. Exp Cell Res 11 (1956) 297–305

    Google Scholar 

  14. Hung DT, LJ Marton, DF Deen, RH Shafer: Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells. Science 221 (1983) 366–368

    Google Scholar 

  15. Kornblith PL, BH Smith, LA Leonard: Response of cultured human brain tumors to nitrosoureas: Correlations with clinical data. Cancer 47 (1981) 255–265

    Google Scholar 

  16. Kornblith PL, PE Szypko: Variations in response of human brain tumors to BCNU in vitro. J Neurosurg 48 (1978) 580–586

    Google Scholar 

  17. Levin VA, WM Wara, RL Davis, et al.: Phase III Comparison of chemotherapy with BCNU and the combination of procarbazine. CCNU, and vincristine administered after radiation therapy and hydroxyurea to patients with malignant gliomas. J Neurosurg 63 (1985) 218–223

    Google Scholar 

  18. Levin VA, K Resser, L McGrath, et al.: PCNU treatment for recurrent malignant gliomas. Cancer Treatment Rep 68 (1984) 969–973

    Google Scholar 

  19. Marton LJ, VA Levin, J Hervatin, et al: Potentiation of the antitumor therapeutic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoro-methylornithine, and ornithine decarboxylase inhibitor. Cancer Res 41 (1981) 4426–4431

    Google Scholar 

  20. Mosmann T: Rapid Colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55–63

    Google Scholar 

  21. Murphy WK, RB Livingston, VG Ruiz, et al.: Serial labeling index determination as a predictor of response in human solid tumors. Cancer Res 35 (1975) 1438–1444

    Google Scholar 

  22. Puck TT, PI Marcus: A rapid method of viable cell titration and colony production with Hela cells in tissue culture. Proc Natl Acad Sci USA 41 (1955) 432–437

    Google Scholar 

  23. Roper PR, B Drewinko: Comparison of in vitro methods to determine drug-induced lethality. Cancer Res 36 (1976) 2182–2188

    Google Scholar 

  24. Rosenblum ML: Chemosensitivity testing for human brain tumors, in Salmon SE (ed): Cloning of Human Tumor Stem Cells, New York: Alan R Liss 259–276 (1980)

    Google Scholar 

  25. Rosenblum ML, DV Dougherty, C Reese, et al.: Potentials and possible pitfalls of human stem cell analysis. Cancer Chemother Pharmacol 6 (1981) 227–235

    Google Scholar 

  26. Rosenblum ML, MA Gerosa, DV Dougherty, et al.: Age-related chemosensitivity on stem cells from human malignant brain tumors. Lancet 1 (1982) 885–887

    Google Scholar 

  27. Rosenblum ML, MA Gerosa: Stem cell sensitivity: Prog Exp Tumor Res 28 (1984) 1–7

    Google Scholar 

  28. Rosenblum ML, MA Gerosa, CB Wilson, et al.: Stem cell studies of human malignant brain tumors. J Neurosurgery 58 (1983) 170–176

    Google Scholar 

  29. Rosenblum ML, DA Vasquez, T Hoshino, et al.: Development of a clonogenic cell assay for human brain tumors. Cancer 41 (1978) 2305–2314

    Google Scholar 

  30. Rutka JT, H Kleppe-Hoifodt, DA Emma, et al.: Characterization of normal human brain cultures. Lab Invest 55 (1986) 71–85

    Google Scholar 

  31. Salmon SE, AW Hamburger, B Soehulen, et al.: Quantitation of differential sensitivity of humantumor stem cells to anti-cancer drugs. N Engl J Med 298 (1978) 1321–1327

    Google Scholar 

  32. Schold SC Jr, MS Mahaley Jr, NA Vick, et al.: Phase II AZQ base chemotherapy trials in patients with anaplastic dupratentorial astrocytic neoplasms. J Clinical Oncol 5 (1987) 464–471

    Google Scholar 

  33. Selby P, RN Buick, I Tannock: A critical appraisal fo the “human tumor stem-cell assay”. N Engl J Med 308 (1983) 129–134

    Google Scholar 

  34. Shapiro JR, PY Pu, AN Mohamed, et al.: Regional heterogeneity in high grade human glioma. Proc Am Assoc Cancer Res 25 (1984) 375

    Google Scholar 

  35. Shapiro Jr, PY Pu, WR Shapiro: Resistant cell types in human gliomas, in Salmon SE, Trent JM (eds) Human Tumor Cloning. Orlando, Grune, and Stratton 122–142 (1984)

    Google Scholar 

  36. Shapiro JR, WKA Yung, WR Shapiro: Isolation, type, and clonal growth of heterogeneous sub-populations of human malignant gliomas. Cancer Res 41 (1981) 2349–2359

    Google Scholar 

  37. Shapiro WR: Treatment of neuroectodermal brain tumors. Ann Neurol 12 (1982) 231–237

    Google Scholar 

  38. Sky-Peck HH: Effect of chemotherapy on the incorporation of (3H)TdR into DNA of human neoplastic tissues. Natl Cancer Inst Monograph 34 (1971) 197–204

    Google Scholar 

  39. Von Hoff DD, J Casper, E Bradley, et al.: Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 70 (1981) 1027–1032

    Google Scholar 

  40. Von Hoff DD, GM Clark, BJ Stogdill, et al.: Prospective clinical trial of a human tumor cloning system. Cancer Res 43 (1983) 1926–1931

    Google Scholar 

  41. Von Hoff DD: In vitro predictive testing: The sulfonamide era. Int J Cell Cloning 5 (1987) 179–190

    Google Scholar 

  42. Weisenthal LM, JA Marsden, PK Dill, CK Macaluso: A noval dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43 (1983) 749–757

    Google Scholar 

  43. Yung WKA, RP Moser: Heterogeneity and Chemosensitivity of cellular DNA in human gliomas. Cancer Bulletin 38 (1986) 7–10

    Google Scholar 

  44. Yung WKA, AM Castellanos, P Van Tassel, et al.: Recombinant interferon beta given intravenously in patients with recurrent malignant glioma. ASCO proceedings 7 (1988) 84

    Google Scholar 

  45. Yung WKA, ZH Siddik, RA Newman, PA Steck: Cytotoxicity and intracellular platinum level of cisplatin, carboplatin, tetraplatin in cultured human glioma cells. AACR proceedings 29 (1988) 343

    Google Scholar 

  46. Yung WKA, PA Steck, J Kolleher, et al.: Growth inhibitory effect of recombinant α and β interferon on human glioma cells. J Neuro-Oncol 5 (1987) 323–330

    Google Scholar 

  47. Yung WKA, JR Shapiro, WR Shapiro: Heterogeneous chemosensitivites of subpopulations of human glioma cells in culture. Cancer Res 42 (1982) 992–998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuro-Oncology, The University of Texas, M.D., Anderson Cancer Center, 1515 Holcombe Boulevard, Box 118, UTMDACC, 77030, Houston, TX, USA

    W. K. Alfred Yung

Authors
  1. W. K. Alfred Yung
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yung, W.K.A. In vitro chemosensitivity testing and its clinical application in human gliomas. Neurosurg. Rev. 12, 197–203 (1989). https://doi.org/10.1007/BF01743984

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01743984

Keywords

Search

Navigation